Home About Login Register Search Archives Announcements

 

Aim and Scope

To provide communication and information exchanging platforms for a broad audience of oncologists, surgeons, medical researchers and professionals working in the field.

Editor-in-Chief

Prof. Dr. Kwong-Kwok Wong
The University of Texas MD Anderson Cancer Center

Indexing and Archiving

Advances in Modern Oncology Research is currently indexed in:

-CAS

  • -CNKI
  • -J-gate
  • -Directory of Open Access Journals (DOAJ)
  • -Google Scholar


AMOR is archived by Portico and the National Library Board of Singapore.

User
Submit Your Manuscript

Downloads

Manuscript Submission Template

ICMJE Conflict of Interest Form

Events

Article Tools
Print this article
Indexing metadata
How to cite item
Finding References
Email this article (Login required)
Email the author (Login required)
Post a Comment (Login required)

Tweets by @AMOR_PiscoMed

Keywords bioinformatics breast cancer breast carcinoma cancer case report chemotherapy cisplatin epidemiology immunotherapy mutation non-small cell lung cancer omics oncology ovarian cancer prostate cancer radiotherapy rectal cancer survival targeted therapy therapy treatment
Home > Vol 2, No 5 (2016) > Abdel-Rahman

Embracing the role of real life studies in the management of rare cancers

Abstract - 1144 PDF - 607
Omar Abdel-Rahman

Abstract


For commonly occurring cancers, as well as situations or conditions that are frequently encountered in oncological setting, plenty of prospective data are available to oncologists or medical practitioners to facilitate the decision making process[1]. However, for rare cancers and atypical scenarios, there are limited references in the current literature. Understandably, this is attributed to the difficulty in recruiting enough patients to systematically study such rare manifestations. Under these circumstances, the importance of real life data that are collected via population-based studies, case series, and case reports is especially significant[2].

In the current issue of AMOR, the journal features three case reports that describe distinctly uncommon oncological scenarios. In one report, Vafaii and Shao highlighted the stepwise development of classical Hodgkin lymphoma (cHL) from diffuse large B cell lymphoma (DLBCL) via precursor Reed-Sternberg/Hodgkin cells, as confirmed via multiple biopsies[3]. They suggested that cHL and DLBCL can be clonally related, even when developing metachronously in the same patient, based on the presence of a hybrid intermediate stage. Meanwhile, Xian and colleagues reported the surgical management of brachial plexus pain that is caused by Pancoast tumor[4]. According to them, the condition closely resembles the symptoms of brachial plexus injury and thus, the underlying cause is easily misdiagnosed. Finally, Coehlo and co-workers presented a report on the prolonged disease control of esthesioneuroblastoma using a multimodality approach, combining surgery, radiotherapy, and chemotherapy to derive an effective treatment strategy[5]. It is noteworthy that despite an initial distant metastasis setback, the patient responded positively to palliative chemotherapy, thus proving the value of the much debated approach[6].

In short, these case reports are an invaluable addition to existing medical literature concerning the diagnoses and management of infrequently encountered malignancies and their associated conditions. Gaining a better understanding of these rare diseases will equip medical practitioners with the right information to devise an appropriate treatment strategy and thus, improve their patients’ long term prognosis.


Keywords


rare cancers; case studies; prospective data; treatment protocols

Full Text:

PDF

References


Sohal DPS, Rini BI, Khorana AA, Dreicer R, Abraham J, et al. Prospective Clinical Study of Precision Oncology in Solid Tumors. JNCI J Natl Cancer Inst 2016; 108(3): 1–3. doi: 10.1093/jnci/djv332.


Gordon EM, Hall FL. Noteworthy clinical case studies in cancer gene therapy: Tumor-targeted Rexin-G advances as an efficacious anti-cancer agent. Int J Oncol 2010; 36: 1341–1353. doi: 10.3892/ijo_00000619.


Vafaii P and Shao H. Stepwise development of classical Hodgkin lymphoma from diffuse large B-cell lymphoma. Adv Mod Oncol Res 2016; 2(5): 292–297. http://dx.doi. org/ 10.18282/amor.v2.i5.147.


Xian H, Cong R, Ren W, Lian K. A case study and liter-ature review of surgical treatment for brachial plexus pain caused by Pancoast syndrome. Adv Mod Oncol Res 2016; 2(5): 279–283. http://dx.doi.org/10.18282/amor.v2.15.150.


Coelho A, Águas L, Osório L, Linhares P. Esthesioneu-roblastoma: A case with prolonged disease control. Adv Mod Oncol Res 2016; 2(5): 284–291. http://dx.doi.org/10. 18282/amor.v2.i5.112.


Roeland EJ, LeBlanc TW. Palliative chemotherapy: Oxymoron or misunderstanding? BMC Palliat Care 2016; 15(33): 1–3. http://dx/doi.org/10.1186/s12904-016-0109-4.





DOI: http://dx.doi.org/10.18282/amor.v2.i5.175

Refbacks

  • There are currently no refbacks.

Comments on this article

  • Considering everything.
    by Rob schneider (2018-04-27)
  • Collection (PS3) 2009
    by EduardaPeres Magalhães (2018-06-16)
  • Muito bom
    by MarianaNeves Beira-Mar (2018-06-23)
  • Funciona Inclusive? 【SAIBA TUDO】
    by MarianaFigueiroa Torres (2018-06-23)
  • Muito bom
    by SophieXisco Calixto (2018-07-03)
  • Muito bom
    by JoanaResende Muniz (2018-07-11)
  • Gel Reduction Emagrece
    by Alex Rocha (2018-09-05)
  • Como Parar De Roncar Funciona
    by Alex Rocha (2018-09-06)
  • Levenza Caps Funciona
    by Alex Rocha (2019-04-16)
View all comments


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Bookmark and Share
                                       

© 2017 by PiscoMed Publishing Pte Ltd